Cargando…

Management of attention deficit/hyperactivity disorder and the use of stimulants in prison. Evaluation of the risks and benefits

Detalles Bibliográficos
Autor principal:	Fructuoso, A
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Sociedad Española de Sanidad Penitenciaria 2019
Materias:	Letters to the Editor
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6813661/ https://www.ncbi.nlm.nih.gov/pubmed/31642863

Ejemplares similares

Use of Stimulants in Patients with Psychosis Having Past History of or Co-occurring Attention Deficit Hyperactivity Disorder: Is it Safe?
por: Purkayastha, Sumedha, et al.
Publicado: (2019)

Neurobiology of Attention Deficit Hyperactivity Disorder in moya moya disease
por: Suravi, Patra, et al.
Publicado: (2020)

Pain and Attention-Deficit/Hyperactivity Disorder: The Case of Margaret Mitchell
por: Kasahara, Satoshi, et al.
Publicado: (2021)

Pediatric moyamoya disease presenting as attention deficit hyperactivity disorder: Time to pay attention
por: Patra, Suravi, et al.
Publicado: (2019)

Does Electroencephalography Contribute to Examining Children with Attention Deficit Hyperactivity Disorder?
por: FAYYAZI, Afshin, et al.
Publicado: (2014)

Decreased Brain Surface Complexity in Children With Attention Deficit Hyperactivity Disorder
por: Choi, Jin Joo, et al.
Publicado: (2022)

Neurofeedback on Reward Processing among Children with Attention Deficit/Hyperactivity Disorder
por: Etemadi, Niloofar, et al.
Publicado: (2023)

The economic consequences of attention-deficit hyperactivity disorder in the Scottish prison system
por: Young, Susan, et al.
Publicado: (2018)

Prisoners with Attention Deficit Hyperactivity Disorder: Co-morbidities & Service Pathways
por: Rawat, A., et al.
Publicado: (2022)

Autoantibodies targeting neurotransmitter biosynthetic enzymes in attention-deficit/hyperactivity disorder (ADHD)
por: Hegvik, Tor-Arne, et al.
Publicado: (2013)

The Effectiveness of mHealth Apps in the Rehabilitation of Children with Attention-deficit Hyperactivity Disorder
por: BASHIRI, Azadeh, et al.
Publicado: (2018)

More evidence and attention are needed to clarify the correlation between moyamoya disease and attention deficit hyperactivity disorder
por: Yu, Jin, et al.
Publicado: (2020)

Clinical features and suicidal behavior in major depression with comorbid attention-deficit hyperactivity disorder
por: Menon, Vikas, et al.
Publicado: (2020)

Management of attention-deficit hyperactivity disorder
por: Verma, Rohit, et al.
Publicado: (2011)

Evaluation of Attention-Deficit Hyperactivity Disorder Risk Factors
por: Golmirzaei, Javad, et al.
Publicado: (2013)

Health-related quality of life in prisoners with attention-deficit hyperactivity disorder and head injury
por: Young, Susan, et al.
Publicado: (2018)

Stimulant Induced Movement Disorders in Attention Deficit Hyperactivity Disorder
por: Nam, Seok-Hyun, et al.
Publicado: (2022)

Yoga for the Management of Attention-Deficit/Hyperactivity Disorder
por: Gunaseelan, Luxhman, et al.
Publicado: (2021)

Atomoxetine-Associated Eyebrow Alopecia in a Girl With Attention-Deficit/Hyperactivity Disorder
por: Zhang, Ying, et al.
Publicado: (2021)

Biological correlates of attention deficit hyperactivity disorder and specific learning disability, following stroke in a young child
por: Tripathi, Praveen, et al.
Publicado: (2015)

Combined Medication with Stimulants and Non-stimulants for Attention-deficit/hyperactivity Disorder
por: Bahn, Geon Ho, et al.
Publicado: (2021)

Authors’ Reply to Pande et al. Comment on “Extended-Release Viloxazine Compared to Atomoxetine for Attention Deficit Hyperactivity Disorder”
por: Price, Maxwell Z., et al.
Publicado: (2023)

Evaluation of Knowledge and Attitude of Parents of Attention Deficit/Hyperactivity Disorder Children towards Attention Deficit/Hyperactivity Disorder in Clinical Samples
por: Dodangi, Nasrin, et al.
Publicado: (2017)

AOD Use and Attention Deficit/Hyperactivity Disorder
por: Wilens, Timothy E.
Publicado: (1998)

Does attention‐deficit hyperactivity disorder medication reduce entrepreneurship?
por: Peltonen, Juhana, et al.
Publicado: (2020)

Is it Attention Deficit Hyperactivity Disorder (ADHD) or Stimulant use disorder ? How is ADHD diagnosed?
por: Sud, N.
Publicado: (2022)

Attention-Deficit/Hyperactivity Disorder and Mortality Risk in Taiwan
por: Chen, Vincent Chin-Hung, et al.
Publicado: (2019)

Adult Attention-Deficit/Hyperactivity Disorder and the Risk of Dementia
por: Levine, Stephen Z., et al.
Publicado: (2023)

Transcriptomic risk scores for attention deficit/hyperactivity disorder
por: Cabana-Domínguez, Judit, et al.
Publicado: (2023)

The history of attention deficit hyperactivity disorder
por: Lange, Klaus W., et al.
Publicado: (2010)

Stigma in attention deficit hyperactivity disorder
por: Mueller, Anna K., et al.
Publicado: (2012)

Attention Deficit Hyperactivity Disorder and Athletes
por: White, Russell D., et al.
Publicado: (2014)

Driving and attention deficit hyperactivity disorder
por: Fuermaier, Anselm B. M., et al.
Publicado: (2015)

Genetics of attention deficit hyperactivity disorder
por: Faraone, Stephen V., et al.
Publicado: (2018)

Neuroimaging in attention-deficit/hyperactivity disorder
por: Pereira-Sanchez, Victor, et al.
Publicado: (2021)

Attention-deficit/hyperactive disorder updates
por: Kessi, Miriam, et al.
Publicado: (2022)

Use of Children’s Communication Checklist-2 to identify Communication Problems in Kannada Speaking Preschool Children with Attention Deficit Hyperactivity Disorder: A Preliminary Study
por: Girimaji, Akhila S., et al.
Publicado: (2023)

Attention Deficit Hyperactivity Disorder (ADHD) among longer-term prison inmates is a prevalent, persistent and disabling disorder
por: Ginsberg, Ylva, et al.
Publicado: (2010)

Attention-deficit hyperactivity disorder (ADHD) stimulant medications as cognitive enhancers
por: Advokat, Claire, et al.
Publicado: (2013)

Relationship Between Attention Deficit Hyperactivity Disorder and Alcohol Dependence: A Genetic View
por: Wang, Ke-Sheng
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_vl8d2c7e6ug95oqu8qnqqps4cb